The protooncogene MET (c-met) is amplified in human gliomas and causes increased activity of its downstream targets [26], resulting in enhanced proliferation, invasion, migration, angiogenesis and survival of malignant gliomas [25]. The gene discussed is MET; the disease is malignant glioma.